ATE273715T1 - Alkyldextran-polyalcohol arzneimittel-komplexe - Google Patents
Alkyldextran-polyalcohol arzneimittel-komplexeInfo
- Publication number
- ATE273715T1 ATE273715T1 AT97924325T AT97924325T ATE273715T1 AT E273715 T1 ATE273715 T1 AT E273715T1 AT 97924325 T AT97924325 T AT 97924325T AT 97924325 T AT97924325 T AT 97924325T AT E273715 T1 ATE273715 T1 AT E273715T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyldextrane
- polyalcohol
- medicinal
- complexes
- spacer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14442196 | 1996-06-06 | ||
PCT/JP1997/001914 WO1997046260A1 (en) | 1996-06-06 | 1997-06-05 | Drug complexes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE273715T1 true ATE273715T1 (de) | 2004-09-15 |
Family
ID=15361795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97924325T ATE273715T1 (de) | 1996-06-06 | 1997-06-05 | Alkyldextran-polyalcohol arzneimittel-komplexe |
Country Status (17)
Country | Link |
---|---|
US (2) | US6436912B1 (de) |
EP (1) | EP0916348B1 (de) |
JP (1) | JP4137183B2 (de) |
KR (1) | KR20000016558A (de) |
CN (1) | CN1227499A (de) |
AT (1) | ATE273715T1 (de) |
AU (1) | AU723392B2 (de) |
CA (1) | CA2257245A1 (de) |
DE (1) | DE69730332T2 (de) |
DK (1) | DK0916348T3 (de) |
EA (1) | EA001550B1 (de) |
ES (1) | ES2229354T3 (de) |
ID (1) | ID18298A (de) |
NO (1) | NO985666L (de) |
PT (1) | PT916348E (de) |
TW (1) | TW527183B (de) |
WO (1) | WO1997046260A1 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH071238U (ja) * | 1993-06-11 | 1995-01-10 | 株式会社大井製作所 | ドアロック操作用のロッド連結装置 |
TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
TW409058B (en) | 1996-06-06 | 2000-10-21 | Daiichi Seiyaku Co | Method for preparation of a drug complex |
EP1080732A4 (de) * | 1998-05-22 | 2004-08-25 | Daiichi Seiyaku Co | Medikamentzusammenstellung |
MXPA01004239A (es) * | 1998-10-30 | 2002-06-04 | Daiichi Seiyaku Co | Compuesto dds y metodo para la medicion del mismo. |
DE60039998D1 (de) * | 1999-10-15 | 2008-10-02 | Daiichi Sankyo Co Ltd | Pentacyclische taxan-verbindungen |
US6677456B2 (en) | 1999-10-15 | 2004-01-13 | Daiichi Pharmaceutical Co., Ltd. | Pentacyclic taxan compound |
KR20030031502A (ko) * | 2000-06-29 | 2003-04-21 | 다이이찌 세이야꾸 가부시기가이샤 | 디디에스 화합물 및 그의 제조방법 |
MXPA03000387A (es) | 2000-07-13 | 2003-09-22 | Daiichi Seiyaku Co | Derivados de 4-fenil-piridina como antagonistas del receptor de neuroquinina-1. |
US20030092608A1 (en) * | 2001-08-21 | 2003-05-15 | Takayuki Kawaguchi | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor |
TWI313609B (en) * | 2001-08-21 | 2009-08-21 | Mitsubishi Tanabe Pharma Corp | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor |
TW200306314A (en) * | 2002-04-16 | 2003-11-16 | Tanabe Seiyaku Co | Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation |
EP1572242B1 (de) * | 2002-12-13 | 2014-04-16 | Immunomedics, Inc. | Immun-conjugate mit einem intrazellular spaltbaren linker |
DK1725249T3 (en) * | 2003-11-06 | 2014-03-17 | Seattle Genetics Inc | Monomethylvaline compounds capable of conjugating to ligands. |
CN101238142B (zh) * | 2005-02-18 | 2012-11-14 | 国立大学法人德岛大学 | 含聚氧化烯链的脂质衍生物及含有该衍生物的脂质膜结构体 |
CN100516067C (zh) | 2006-01-10 | 2009-07-22 | 上海恒瑞医药有限公司 | 具有抗肿瘤活性的紫杉酚衍生物 |
US9895449B2 (en) | 2010-05-25 | 2018-02-20 | Syndevrx, Inc. | Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof |
CN107141410B (zh) | 2010-05-25 | 2022-12-09 | 辛德弗雷克斯公司 | 聚合物缀合的MetAP2抑制剂及其应用的治疗方法 |
WO2014057687A1 (ja) | 2012-10-11 | 2014-04-17 | 第一三共株式会社 | 抗体-薬物コンジュゲート |
JP6272230B2 (ja) | 2012-10-19 | 2018-01-31 | 第一三共株式会社 | 親水性構造を含むリンカーで結合させた抗体−薬物コンジュゲート |
AU2014250983B2 (en) | 2013-04-10 | 2019-04-11 | Syndevrx, Inc. | MetAP2 inhibitors and methods of treating obesity |
WO2015071841A1 (en) | 2013-11-12 | 2015-05-21 | Druggability Technologies Holdings Limited | Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
CA2933666C (en) | 2013-12-25 | 2021-08-03 | Sapporo Medical University | Anti-trop2 antibody-drug conjugate |
KR102362920B1 (ko) | 2014-01-31 | 2022-02-14 | 다이이찌 산쿄 가부시키가이샤 | 항-her2 항체-약물 접합체 |
SG11201608309PA (en) | 2014-04-10 | 2016-11-29 | Daiichi Sankyo Co Ltd | Anti-her3 antibody-drug conjugate |
WO2015155976A1 (ja) * | 2014-04-10 | 2015-10-15 | 第一三共株式会社 | 抗her2抗体-薬物コンジュゲート |
IL290959B2 (en) | 2015-06-29 | 2023-04-01 | Daiichi Sankyo Co Ltd | Preparations containing antibody-drug conjugates and methods for their production |
EP3386956B1 (de) | 2015-12-10 | 2021-07-14 | Syndevrx, Inc. | Fumagillolderivate und polymorphe davon |
WO2017123603A1 (en) | 2016-01-11 | 2017-07-20 | Syndevrx, Inc. | Treatment for tumors driven by metabolic dysfunction |
JPWO2018066626A1 (ja) | 2016-10-07 | 2019-07-18 | 第一三共株式会社 | 抗her2抗体−薬物コンジュゲート投与による耐性癌の治療 |
CN110049779A (zh) | 2016-12-12 | 2019-07-23 | 第一三共株式会社 | 抗体-药物缀合物和免疫检查点抑制剂的组合 |
CA3050668C (en) | 2017-01-17 | 2023-08-15 | Daiichi Sankyo Company, Limited | Anti-gpr20 antibody and anti-gpr20 antibody-drug conjugate |
TW202330036A (zh) | 2017-05-15 | 2023-08-01 | 日商第一三共股份有限公司 | 抗體-藥物結合物之製造方法 |
KR20200041993A (ko) | 2017-08-31 | 2020-04-22 | 다이이찌 산쿄 가부시키가이샤 | 항체-약물 콘주게이트의 개량 제조 방법 |
IL272964B2 (en) | 2017-08-31 | 2024-02-01 | Daiichi Sankyo Co Ltd | Production method for antibody-drug conjugates |
RS64379B1 (sr) | 2018-05-18 | 2023-08-31 | Glycotope Gmbh | Anti-muc1 antitelo |
JP2022512826A (ja) | 2018-10-26 | 2022-02-07 | シンデブルックス,インコーポレイティド | MetAP2阻害剤のバイオマーカーとその応用 |
WO2021007435A1 (en) | 2019-07-10 | 2021-01-14 | Cybrexa 2, Inc. | Peptide conjugates of cytotoxins as therapeutics |
AU2020311925A1 (en) | 2019-07-10 | 2022-02-03 | Cybrexa 3, Inc. | Peptide conjugates of microtubule-targeting agents as therapeutics |
US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59220197A (ja) * | 1983-05-30 | 1984-12-11 | Snow Brand Milk Prod Co Ltd | 新規な含窒素多糖体およびその製造方法 |
JP2604930B2 (ja) | 1990-12-14 | 1997-04-30 | 株式会社ディ・ディ・エス研究所 | ヒアルロン酸およびコンドロイチン誘導体 |
ATE166361T1 (de) | 1991-02-21 | 1998-06-15 | Drug Delivery System Inst Ltd | Carboxymethylmannoglukan und derivate davon |
JP3359955B2 (ja) | 1992-07-16 | 2002-12-24 | 第一製薬株式会社 | 抗腫瘍剤 |
PT640622E (pt) | 1993-02-26 | 2000-11-30 | Drug Delivery System Inst Ltd | Derivados de polissacaridos e veiculos para farmacos |
JPH0784481A (ja) | 1993-06-26 | 1995-03-31 | Ricoh Co Ltd | 画像形成装置 |
US5811510A (en) * | 1995-04-14 | 1998-09-22 | General Hospital Corporation | Biodegradable polyacetal polymers and methods for their formation and use |
SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
TW409058B (en) | 1996-06-06 | 2000-10-21 | Daiichi Seiyaku Co | Method for preparation of a drug complex |
TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
EP1080732A4 (de) | 1998-05-22 | 2004-08-25 | Daiichi Seiyaku Co | Medikamentzusammenstellung |
MXPA01004239A (es) | 1998-10-30 | 2002-06-04 | Daiichi Seiyaku Co | Compuesto dds y metodo para la medicion del mismo. |
-
1997
- 1997-05-31 TW TW086107455A patent/TW527183B/zh not_active IP Right Cessation
- 1997-06-05 DK DK97924325T patent/DK0916348T3/da active
- 1997-06-05 EP EP97924325A patent/EP0916348B1/de not_active Expired - Lifetime
- 1997-06-05 WO PCT/JP1997/001914 patent/WO1997046260A1/ja active IP Right Grant
- 1997-06-05 DE DE69730332T patent/DE69730332T2/de not_active Expired - Lifetime
- 1997-06-05 PT PT97924325T patent/PT916348E/pt unknown
- 1997-06-05 EA EA199900004A patent/EA001550B1/ru not_active IP Right Cessation
- 1997-06-05 AU AU29787/97A patent/AU723392B2/en not_active Ceased
- 1997-06-05 CA CA002257245A patent/CA2257245A1/en not_active Abandoned
- 1997-06-05 JP JP50042198A patent/JP4137183B2/ja not_active Expired - Fee Related
- 1997-06-05 KR KR1019980710148A patent/KR20000016558A/ko active IP Right Grant
- 1997-06-05 AT AT97924325T patent/ATE273715T1/de not_active IP Right Cessation
- 1997-06-05 CN CN97197008A patent/CN1227499A/zh active Pending
- 1997-06-05 ID IDP971928A patent/ID18298A/id unknown
- 1997-06-05 ES ES97924325T patent/ES2229354T3/es not_active Expired - Lifetime
- 1997-06-05 US US09/147,342 patent/US6436912B1/en not_active Expired - Fee Related
-
1998
- 1998-12-04 NO NO985666A patent/NO985666L/no not_active Application Discontinuation
-
2002
- 2002-05-28 US US10/155,170 patent/US6838450B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2229354T3 (es) | 2005-04-16 |
US6838450B2 (en) | 2005-01-04 |
EA001550B1 (ru) | 2001-04-23 |
KR20000016558A (ko) | 2000-03-25 |
EA199900004A1 (ru) | 1999-06-24 |
CN1227499A (zh) | 1999-09-01 |
DK0916348T3 (da) | 2004-12-06 |
JP4137183B2 (ja) | 2008-08-20 |
AU2978797A (en) | 1998-01-05 |
NO985666D0 (no) | 1998-12-04 |
EP0916348A1 (de) | 1999-05-19 |
DE69730332T2 (de) | 2005-09-22 |
PT916348E (pt) | 2004-10-29 |
EP0916348B1 (de) | 2004-08-18 |
NO985666L (no) | 1999-02-04 |
TW527183B (en) | 2003-04-11 |
US6436912B1 (en) | 2002-08-20 |
WO1997046260A1 (en) | 1997-12-11 |
DE69730332D1 (de) | 2004-09-23 |
ID18298A (id) | 1998-03-26 |
AU723392B2 (en) | 2000-08-24 |
CA2257245A1 (en) | 1997-12-11 |
US20030171262A1 (en) | 2003-09-11 |
EP0916348A4 (de) | 2000-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE273715T1 (de) | Alkyldextran-polyalcohol arzneimittel-komplexe | |
NO301829B1 (no) | 2-pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og farmasöytiske preparater basert på disse | |
EP0787009A4 (de) | Krebs hemmende peptide | |
GEP20012413B (en) | Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents | |
AU6701890A (en) | Process for the production of biologically active protein | |
ATE386808T1 (de) | Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel | |
ZA91353B (en) | Pharmaceutical and cosmetic compositions | |
CA2192944A1 (en) | Stimulation of Hair Growth by Peptide-Copper Complexes | |
TW225532B (de) | ||
HRP930239A2 (en) | Anti-inflamatory 4-aminophenol derivatives | |
DE69124705D1 (de) | Hexapeptide als liganden des anaphylatoxin-rezeptors | |
FI940375A (fi) | Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa | |
ATE157011T1 (de) | Verabreichung von mitteln | |
AU1064988A (en) | Polymer complexes of metals useful as pharmaceutical agents | |
CA2163197A1 (en) | Tri(platinum) complexes | |
CA2155017A1 (en) | Vpr function and activity | |
ATE363214T1 (de) | Löslicher natamycin-proteinkomplex | |
DE69001334T2 (de) | Uebergangsmetall-tris-dithiolen und verwandte komplexe als vorprodukte fuer aktive katalysatoren. | |
IT8868117A0 (it) | Solfonammidi di benzilidene canfora derivanti da amminoacidi e loro impiego in cosmesi particolarmente come filtri solari | |
ATE186734T1 (de) | L-lysyl-glycyl-l-histidin und entsprechende pharmazeutische zusammensetzungen zur wundheilung | |
EA199900998A1 (ru) | Полутвердый фармацевтический препарат, содержащий декскетопрофентрометамол | |
FI933507A (fi) | Bisyklopolyatsamakrosyklofosfonihappoja, niiden komplekseja ja konjugaatteja käytettäväksi varjoaineina ja menetelmä niiden valmistamiseksi | |
ATE137487T1 (de) | Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren | |
FI933506A (fi) | Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaatteja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina | |
ATE36957T1 (de) | N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0916348 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |